Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice

Δ(9)-Tetrahydrocannbinol (THC), the primary active constituent of Cannabis sativa, has long been known to reduce opioid withdrawal symptoms. Although THC produces most of its pharmacological actions through the activation of CB(1) and CB(2) cannabinoid receptors, the role these receptors play in red...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ramesh, Divya, Ross, Gracious R., Schlosburg, Joel E., Owens, Robert A., Abdullah, Rehab A., Kinsey, Steven G., Long, Jonathan Z., Nomura, Daniel K., Sim-Selley, Laura J., Cravatt, Benjamin F., Akbarali, Hamid I., Lichtman, Aron H.
Formato: Artigo
Idioma:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2011
Assuntos:
Behavioral Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186294/
https://ncbi.nlm.nih.gov/pubmed/21719468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.181370
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares